BioSpace News Archive

Researchers Demonstrate Therapeutic Antibodies Stabilize Nerve-Muscle Synapses in a Mouse Model of ALS

Research funded by The ALS Association’s Lawrence and Isabel Barnett Drug Development Program recently uncovered a new way to slow muscle paralysis in mice with ALS, findings that could point to new approaches to therapy for people with ALS.

February 20, 2018
·
3 min read
Business

Ionis Licences New Antisense Drug for Kidney Disease to AstraZeneca

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it has licensed IONIS-AZ5-2.5 Rx (AZD2373) to the global, science-led biopharmaceutical company AstraZeneca (NYSE: AZN).

February 20, 2018
·
5 min read
Genetown

Biostage Closes $1 Million Private Placement

February 20, 2018
·
3 min read
Business

Takeda Partners With Wave Life Sciences

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it has entered into a research, development and commercial collaboration and multi-program option agreement with Wave Life Sciences Ltd.

February 20, 2018
·
6 min read
Drug Development

Catheter Precision Launches Clinical Trial for Its VIVO™ Non-Invasive Mapping System

Study Expected to Expand to Five Hospitals and Evaluate Accuracy of the VIVO System.

February 20, 2018
·
3 min read
Cedars-Sinai and Emulate, Inc. Advance Precision Medicine With Organs-on-Chips, Stem Cells

Scientists at Cedars-Sinai and Emulate, Inc. are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient’s genetic makeup and disease variant—a new approach to precision medicine for improving patient care and health.

February 20, 2018
·
6 min read
Business

Cullinan Oncology and MAB Discovery Announce Collaboration to Develop Novel Antibody-Based Therapeutics

Cullinan Oncology, LLC and MAB Discovery GmbH (MABD), announced today the initiation of a collaboration to develop novel antibody therapeutics based on MABD’s unique discovery platform.

February 20, 2018
·
2 min read
Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization

Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.

February 20, 2018
·
2 min read
Business

Attune Medical Promotes Keith Warner to CEO

Attune Medical (formerly Advanced Cooling Therapy) has promoted COO Keith Warner to Chief Executive Officer.

February 20, 2018
·
3 min read